BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2117464)

  • 1. Characterization of new IgG lambda myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myeloma.
    Hamilton MS; Ball J; Bromidge E; Lowe J; Franklin IM
    Br J Haematol; 1990 Jul; 75(3):378-84. PubMed ID: 2117464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of multiple myeloma (IgG, lambda-type)) with pathological plasmacytes and M-protein in the pleural fluid (author's transl)].
    Fukushima K; Ishimi H; Tsutsui D; Morioka S; Nishimura Y; Tanaka T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Jul; 17(7):415-20. PubMed ID: 119889
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin.
    Matsuo Y; Drexler HG; Harashima A; Okochi A; Hasegawa A; Kojima K; Orita K
    Leuk Res; 2004 Aug; 28(8):869-77. PubMed ID: 15203285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytology of myeloma cells.
    Hayhoe FG; Neuman Z
    J Clin Pathol; 1976 Oct; 29(10):916-22. PubMed ID: 824323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelomonocytic myeloma cell line (LB 84-1).
    Durie BG; Grogan TM; Spier C; Vela E; Baum V; Rodriquez MA; Frutiger Y
    Blood; 1989 Feb; 73(3):770-6. PubMed ID: 2492835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term establishment of a human plasmacyte cell line derived from a patient with IgD multiple myeloma. I. Requirement of a plasmacyte-stimulating factor for the proliferation of myeloma cells in tissue culture.
    Jobin ME; Fahey JL; Price Z
    J Exp Med; 1974 Aug; 140(2):494-507. PubMed ID: 4858717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic immunoglobulin content in multiple myeloma.
    Barlogie B; Alexanian R; Pershouse M; Smallwood L; Smith L
    J Clin Invest; 1985 Aug; 76(2):765-9. PubMed ID: 2411762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay for myeloma idiotype.
    Gailani S; Seon BK; Nussbaum A; Henderson ES; Pressman D
    J Natl Cancer Inst; 1977 Jun; 58(6):1553-5. PubMed ID: 405500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phagocytic, lambda light chain, plasma cell myeloma.
    Wirt DP; Grogan TM; Payne CM; Kummet TD; Durie BG; Finley PR; Rollins D
    Am J Clin Pathol; 1983 Jul; 80(1):75-84. PubMed ID: 6190396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vacuolar inclusions with multivesicular structure in leukemic multiple myeloma].
    Fujii H; Nakagawa H; Kanoh T; Matsuyama F; Urata Y
    Rinsho Ketsueki; 1992 Aug; 33(8):1090-4. PubMed ID: 1328702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new human multiple myeloma cell line, UMJF-2, which suppresses antibody production by B-lymphocytes in vitro.
    Farnen JP; Tyrkus M; Hanson CA; Cody RL; Emerson SG
    Leukemia; 1991 Jul; 5(7):574-84. PubMed ID: 1649357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG-lambda plasma cell myeloma with cytoplasmic azurophilic inclusion bodies.
    Kulbacki EL; Wang E
    Am J Hematol; 2010 Jul; 85(7):516-7. PubMed ID: 20127969
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.
    Shimizu K; Ohnishi K; Kunii A
    Clin Exp Immunol; 1982 Dec; 50(3):596-600. PubMed ID: 6819908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inclusions fixing thioflavin T in plasmacytes of IgG lambda myeloma with amylosis].
    Canioni D; Kermarec J
    Arch Anat Cytol Pathol; 1982; 30(5-6):279-83. PubMed ID: 6188417
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monoclonal plasmocytic myeloma with 2 paraproteins, IgG kappa and IgG lambdal].
    Villiamey J; Bouvet JP; Di Menza C; Boccara M
    Nouv Presse Med; 1974 Dec; 3(45):2707-11. PubMed ID: 4142506
    [No Abstract]   [Full Text] [Related]  

  • 16. Biphenotypic plasma cell myeloma.
    Kurt H; Ferreira KA
    Blood; 2019 Apr; 133(14):1611. PubMed ID: 30948370
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment and characterization of a human myeloma cell line (KMM-1).
    Togawa A; Inoue N; Miyamoto K; Hyodo H; Namba M
    Int J Cancer; 1982 May; 29(5):495-500. PubMed ID: 7095894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel type of clonally involved cytoplasmic immunoglobulin-negative cells in multiple myeloma: flow cytometric study.
    Shimazaki C; Gotoh H; Oku N; Ashihara E; Inaba T; Murakami S; Ura Y; Nakagawa M; Fujita N
    Acta Haematol; 1992; 88(2-3):86-91. PubMed ID: 1466204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The proportion of kappa and lambda light chains among monotypic IgG and IgA].
    Nikolić V; Dovezenski N; Milosević-Jovcić N
    Srp Arh Celok Lek; 1986; 114(11-12):991-9. PubMed ID: 3109038
    [No Abstract]   [Full Text] [Related]  

  • 20. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.